Grifols SA (Grifols) is a pharmaceutical and chemical manufacturing company engaged on enhancing the health and well-being of patients worldwide. It is focused on research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. It produces plasma derived protein therapies for patients suffering with rare, chronic and life-threatening infections. Grifols offers biological materials for clinical trials, biotechnology research, manufacturing pharmaceutical and diagnostic products. Grifols provides transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. The company offers its products to hospitals, pharmacies and healthcare professionals. It offers products in the US, Canada, Europe, and Rest of the world. Grifols is headquartered in Barcelona, Spain.

Headquarters Spain

Address C/ Jesus Y Maria, 6, Barcelona, 08022


Telephone 34 935 710000

No of Employees 27,584

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange GRF (MCE)

Revenue (2021) $5.8B -7.6% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -69.5% (2021 vs 2020)

Market Cap* $6.6B

Net Profit Margin (2021) XXX -66.9% (2021 vs 2020)

* As of and is in US$

Access premium data and analytics for Grifols SA

210+

Clinical Trials

Determine Grifols SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

90+

Catalyst Calendar

Proactively evaluate Grifols SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

80+

Pipeline Drugs

Identify which of Grifols SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Grifols SA’s relevant decision makers and contact details.

20+

Marketed Drugs

Understand Grifols SA’s commercialized product portfolio to stay one step ahead of the market.

15+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

160+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

120+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

30+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

16+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

3

IT Software Contracts

Improve competitive bidding with insight into all publicly disclosed IT software contracts by IT solutions areas for Grifols SA (including Enterprise applications, IT Security, Information Management, Cloud Computing, IoT and more).

2

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Grifols SA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Grifols SA’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Bioscience: Albutein
Plasma Derivative Products Alphanate
Diagnostic: Anbinex
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In September, the company signed a pioneering long-term agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada.
2022 Acquisitions/Mergers/Takeovers In April, the company acquired Biotest, a biotechnology company.
2022 Acquisitions/Mergers/Takeovers In April, the company announced the completion of the acquisition of 100% stake of Tiancheng (Germany) Pharmaceutical Holdings AG.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Grifols SA Takeda Pharmaceutical Co Ltd CSL Ltd Omnicell Inc Abeona Therapeutics Inc
Headquarters Spain Japan Australia United States of America United States of America
City Barcelona Chuo-Ku Melbourne Mountain View New York
State/Province - Tokyo Victoria California New York
No. of Employees 27,584 47,347 30,000 3,800 90
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Steven F. Mayer Chairman Executive Board 2022 -
Victor Grifols Deu Co - Chief Executive Officer Executive Board 2017 45
Raimon Grifols Roura Co - Chief Executive Officer Executive Board 2017 58
Victor Grifols Roura Co-Chief Executive Officer Executive Board 2017 -
Alfredo Arroyo Guerra Chief Financial Officer Senior Management 2013 65
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?